The human cell surfaceome of breast tumors

BioMed Research International

Volumn 2013, Issue , 2013, Pages

  Da Cunha, Júlia Pinheiro Chagas ^a,b   Galante, Pedro Alexandre Favoretto ^a,c   De Souza, Jorge Estefano Santana ^a,d   Pieprzyk, Martin ^e   Carraro, Dirce Maria ^f   Old, Lloyd J ^g   Camargo, Anamaria Aranha ^a,c   De Souza, Sandro José ^a,h  

^a LUDWIG INSTITUTE FOR CANCER RESEARCH   (Brazil)

^b INSTITUTO BUTANTAN   (Brazil)

^c HOSPITAL SÍRIO LIBANÊS   (Brazil)

^d Instituto de Bioinformática e Biotecnologia   (Brazil)

^e FLUIDIGM CORPORATION   (United States)

^f A C CAMARGO CANCER CENTER   (Brazil)

^g LUDWIG INSTITUTE FOR CANCER RESEARCH   (Australia)

^h FEDERAL UNIVERSITY OF RIO GRANDE DO NORTE   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM RELEASE ACTIVATED CALCIUM CHANNEL 1; CELL SURFACE PROTEIN; CELL SURFACE RECEPTOR; DYSADHERIN; EPIDERMAL GROWTH FACTOR RECEPTOR 2; FIBROBLAST GROWTH FACTOR RECEPTOR 2; GELATINASE A; GLUCOSE TRANSPORTER 1; MATRIX METALLOPROTEINASE 14; MATRIX METALLOPROTEINASE 15; MYC PROTEIN; TOLL LIKE RECEPTOR 3; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR; MEMBRANE PROTEIN; TUMOR MARKER; TUMOR PROTEIN;

ARTICLE; BREAST CARCINOGENESIS; BREAST CELL; BREAST TUMOR; CANCER STAGING; CANCER THERAPY; CELL PROLIFERATION; CELL SURFACE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIMARY TUMOR; PROTEIN PROTEIN INTERACTION; RNA EXTRACTION; SIGNAL TRANSDUCTION; SOMATIC MUTATION; BIOLOGY; FEMALE; GENE EXPRESSION PROFILING; GENETICS; METABOLISM; TUMOR CELL LINE;

BREAST NEOPLASMS; CELL LINE, TUMOR; COMPUTATIONAL BIOLOGY; FEMALE; GENE EXPRESSION PROFILING; HUMANS; MEMBRANE PROTEINS; NEOPLASM PROTEINS; SIGNAL TRANSDUCTION; TUMOR MARKERS, BIOLOGICAL;

EID: 84885354049     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2013/976816     Document Type: Article

References (37)

1. Jemal A., Siegel R., Ward E., Hao Y., Xu J., Murray T., Thun M. J., Cancer statistics, 2008. CA: A Cancer Journal for Clinicians 2008 58 2 71 96 2-s2.0-41349099104 10.3322/CA.2007.0010 (Pubitemid 351521864)
2. Perou C. M., Sørile T., Eisen M. B., Van De Rijn M., Jeffrey S. S., Ress C. A., Pollack J. R., Ross D. T., Johnsen H., Akslen L. A., Fluge Ø., Pergammenschlkov A., Williams C., Zhu S. X., Lønning P. E., Børresen-Dale A.-L., Brown P. O., Botstein D., Molecular portraits of human breast tumours. Nature 2000 406 6797 747 752 2-s2.0-0034680102 10.1038/35021093
3. Harris L., Fritsche H., Mennel R., Norton L., Ravdin P., Taube S., Somerfield M. R., Hayes D. F., Bast R. C. Jr., American Society of Clinical Oncology 2007 update of recommendations for the use of tumor markers in breast cancer. Journal of Clinical Oncology 2007 25 33 5287 5312 2-s2.0-36849069347 10.1200/JCO.2007.14.2364 (Pubitemid 350232263)
4. van't Veer L. J., Dai H., van de Vijver M. J., He Y. D., Hart A. A. M., Mao M., Peterse H. L., Van Der Kooy K., Marton M. J., Witteveen A. T., Schreiber G. J., Kerkhoven R. M., Roberts C., Linsley P. S., Bernards R., Friend S. H., Gene expression profiling predicts clinical outcome of breast cancer. Nature 2002 415 6871 530 536 2-s2.0-18244409687 10.1038/415530a (Pubitemid 34130608)
5. da Cunha J. P. C., Galante P. A. F., de Souza J. E., De Souza R. F., Carvalho P. M., Ohara D. T., Moura R. P., Oba-Shinja S. M., Marie S. K. N., Silva W. A. Jr., Perez R. O., Stransky B., Pieprzyk M., Moore J., Caballero O., Gama-Rodrigues J., Habr-Gamad A., Kuo W. P., Simpson A. J., Camargo A. A., Old L. J., De Souza S. J., Bioinformatics construction of the human cell surfaceome. Proceedings of the National Academy of Sciences of the United States of America 2009 106 39 16752 16757 2-s2.0-70349744048 10.1073/pnas.0907939106
6. Xia W., Mullin R. J., Keith B. R., Liu L.-H., Ma H., Rusnak D. W., Owens G., Alligood K. J., Spector N. L., Anti-tumor activity of GW572016: a dual tyrosine kinase inhibitor blocks EGF activation of EGFR/erbB2 and downstream Erk1/2 and AKT pathways. Oncogene 2002 21 41 6255 6263 2-s2.0-0037068741 10.1038/sj.onc.1205794
7. Chen H. X., Gore-Langton R. E., Cheson B. D., Clinical trials referral resource: current clinical trials of the anti-VEGF monoclonal antibody bevacizumab. Oncology 2001 15 8 1017 1026 2-s2.0-0035431418
8. Slamon D. J., Clark G. M., Wong S. G., Levin W. J., Ullrich A., McGuire W. L., Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene. Science 1987 235 4785 182 191 2-s2.0-37049183697
9. Owens M. A., Horten B. C., Da Silva M. M., HER2 amplification ratios by fluorescence in situ hybridization and correlation with immunohistochemistry in a cohort of 6556 breast cancer tissues. Clinical Breast Cancer 2004 5 1 63 69 2-s2.0-3042622482 (Pubitemid 38821193)
10. Sjöblom T., Jones S., Wood L. D., Parsons D. W., Lin J., Barber T. D., Mandelker D., Leary R. J., Ptak J., Silliman N., Szabo S., Buckhaults P., Farrell C., Meeh P., Markowitz S. D., Willis J., Dawson D., Willson J. K. V., Gazdar A. F., Hartigan J., Wu L., Liu C., Parmigiani G., Park B. H., Bachman K. E., Papadopoulos N., Vogelstein B., Kinzler K. W., Velculescu V. E., The consensus coding sequences of human breast and colorectal cancers. Science 2006 314 5797 268 274 2-s2.0-33749993417 10.1126/science.1133427 (Pubitemid 44571966)
11. Wood L. D., Parsons D. W., Jones S., Lin J., Sjöblom T., Leary R. J., Shen D., Boca S. M., Barber T., Ptak J., Silliman N., Szabo S., Dezso Z., Ustyanksky V., Nikolskaya T., Nikolsky Y., Karchin R., Wilson P. A., Kaminker J. S., Zhang Z., Croshaw R., Willis J., Dawson D., Shipitsin M., Willson J. K. V., Sukumar S., Polyak K., Ben H. P., Pethiyagoda C. L., Pant P. V. K., Ballinger D. G., Sparks A. B., Hartigan J., Smith D. R., Suh E., Papadopoulos N., Buckhaults P., Markowitz S. D., Parmigiani G., Kinzler K. W., Velculescu V. E., Vogelstein B., The genomic landscapes of human breast and colorectal cancers. Science 2007 318 5853 1108 1113 2-s2.0-36248962105 10.1126/science.1145720 (Pubitemid 350134889)
12. Leary R. J., Lin J. C., Cummins J., Boca S., Wood L. D., Parsons D. W., Jones S., Sjöblom T., Park B.-H., Parsons R., Willis J., Dawson D., Willson J. K. V., Nikolskaya T., Nikolsky Y., Kopelovich L., Papadopoulos N., Pennacchio L. A., Wang T.-L., Markowitz S. D., Parmigiani G., Kinzler K. W., Vogelstein B., Velculescu V. E., Integrated analysis of homozygous deletions, focal amplifications, and sequence alterations in breast and colorectal cancers. Proceedings of the National Academy of Sciences of the United States of America 2008 105 42 16224 16229 2-s2.0-55849099654 10.1073/pnas.0808041105
13. Stamps A. C., Davies S. C., Burman J., O'Hare M. J., Analysis of proviral integration in human mammary epithelial cell lines immortalized by retroviral infection with a temperature-sensitive SV40 T- antigen construct. International Journal of Cancer 1994 57 6 865 874 2-s2.0-0028341062 10.1002/ijc.2910570616 (Pubitemid 24216824)
14. Livak K. J., Schmittgen T. D., Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCT method. Methods 2001 25 4 402 408 2-s2.0-0035710746 10.1006/meth.2001.1262 (Pubitemid 34164012)
15. Singh J., Young L., Handelsman D. J., Dong Q., Molecular cloning and characterization of a novel androgen repressible gene expressed in the prostate epithelium. Gene 2005 348 1-2 55 63 2-s2.0-15744402936 10.1016/j.gene.2004.12. 047 (Pubitemid 40410016)
16. Egland K. A., Liu X. F., Squires S., Nagata S., Man Y.-G., Bera T. K., Onda M., Vincent J. J., Strausberg R. L., Lee B., Pastan I., High expression of a cytokeratin-associated protein in many cancers. Proceedings of the National Academy of Sciences of the United States of America 2006 103 15 5929 5934 2-s2.0-33645800175 10.1073/pnas.0601296103
17. Eckert A. W., Lautner M. H. W., Taubert H., Schubert J., Bilkenroth U., Expression of Glut-1 is a prognostic marker for oral squamous cell carcinoma patients. Oncology Reports 2008 20 6 1381 1385 2-s2.0-59249093261 10.3892/or-00000156
18. Ozcan A., Shen S. S., Zhai Q., Truong L. D., Expression of GLUT1 in primary renal tumors: morphologic and biologic implications. American Journal of Clinical Pathology 2007 128 2 245 254 2-s2.0-34547909267 10.1309/ HV6NJVRQKK4QHM9F (Pubitemid 47262622)
19. Tsukioka M., Matsumoto Y., Noriyuki M., Yoshida C., Nobeyama H., Yoshida H., Yasui T., Sumi T., Honda K.-I., Ishiko O., Expression of glucose transporters in epithelial ovarian carcinoma: correlation with clinical characteristics and tumor angiogenesis. Oncology Reports 2007 18 2 361 367 2-s2.0-34548544377
20. Haber R. S., Rathan A., Weiser K. R., Pritsker A., Itzkowitz S. H., Bodian C., Slater G., Weiss A., Burstein D. E., GLUT1 glucose transporter expression in colorectal carcinoma: a marker for poor prognosis. Cancer 1998 83 34 40 (Pubitemid 28299626)
21. Haber R. S., Weiser K. R., Pritsker A., Reder I., Burstein D. E., Glut1 glucose transporter expression in benign and malignant thyroid nodules. Thyroid 1997 7 3 363 667 2-s2.0-0030750652 (Pubitemid 27295132)
22. Youn W. K., Park Y.-K., Tae Y. Y., Sang M. L., Expression of the GLUT1 glucose transporter in gallbladder carcinomas. Hepato-Gastroenterology 2002 49 46 907 911 2-s2.0-0036328373 (Pubitemid 34809746)
23. Dempsey P. W., Doyle S. E., He J. Q., Cheng G., The signaling adaptors and pathways activated by TNF superfamily. Cytokine and Growth Factor Reviews 2003 14 3-4 193 209 2-s2.0-0038320263 10.1016/S1359-6101(03)00021-2 (Pubitemid 36693141)
24. Rudchenko S., Scanlan M., Kalantarov G., Yavelsky V., Levy C., Estabrook A., Old L., Chan G. L., Lobel L., Trakht I., A human monoclonal autoantibody to breast cancer identifies the PDZ domain containing protein GIPC1 as a novel breast cancer-associated antigen. BMC Cancer 2008 8 article 248 2-s2.0-51349114096 10.1186/1471-2407-8-248
25. Kirikoshi H., Katoh M., Expression of human GIPC1 in normal tissues, cancer cell lines, and primary tumors. International Journal of Molecular Medicine 2002 9 5 509 513 2-s2.0-0036585058
26. Lambaerts K., Wilcox-Adelman S. A., Zimmermann P., The signaling mechanisms of syndecan heparan sulfate proteoglycans. Current Opinion in Cell Biology 2009 21 5 662 669 2-s2.0-70349332773 10.1016/j.ceb.2009.05.002
27. Orend G., Huang W., Olayioye M. A., Hynes N. E., Chiquet-Ehrismann R., Tenascin-C blocks cell-cycle progression of anchorage-dependent fibroblasts on fibronectin through inhibition of syndecan-4. Oncogene 2003 22 25 3917 3926 2-s2.0-0038339013 10.1038/sj.onc.1206618 (Pubitemid 36819665)
28. MacDonald B. T., Tamai K., He X., Wnt/ β -catenin signaling: components, mechanisms, and diseases. Developmental Cell 2009 17 1 9 26 2-s2.0-67650230896 10.1016/j.devcel.2009.06.016
29. Rozanov D. V., Savinov A. Y., Williams R., Liu K., Golubkov V. S., Krajewski S., Strongin A. Y., Molecular signature of MT1-MMP: transactivation of the downstream universal gene network in cancer. Cancer Research 2008 68 11 4086 4096 2-s2.0-49249137190 10.1158/0008-5472.CAN-07-6458
30. Tsunezuka Y., Kinoh H., Takino T., Watanabe Y., Okada Y., Shinagawa A., Sato H., Seiki M., Expression of membrane-type matrix metalloproteinase 1 (MT1-MMP) in tumor cells enhances pulmonary metastasis in an experimental metastasis assay. Cancer Research 1996 56 24 5678 5683 2-s2.0-0029753004 (Pubitemid 26422172)
31. Chun T.-H., Sabeh F., Ota I., Murphy H., McDonagh K. T., Holmbeck K., Birkedal-Hansen H., Allen E. D., Weiss S. J., MT1-MMP-dependent neovessel formation within the confines of the three-dimensional extracellular matrix. Journal of Cell Biology 2004 167 4 757 767 2-s2.0-9444274032 10.1083/jcb.200405001 (Pubitemid 39565155)
32. Sato H., Kinoshita T., Takino T., Nakayama K., Seiki M., Activation of a recombinant membrane type 1-matrix metalloproteinase (MT1-MMP) by furin and its interaction with tissue inhibitor of metalloproteinases (TIMP)-2. FEBS Letters 1996 393 1 101 104 2-s2.0-0030577022 10.1016/0014-5793(96)00861-7 (Pubitemid 26298239)
33. Holmbeck K., Bianco P., Caterina J., Yamada S., Kromer M., Kuznetsov S. A., Mankani M., Gehron Robey P., Poole A. R., Pidoux I., Ward J. M., Birkedal-Hansen H., MT1-MMP-deficient mice develop dwarfism, osteopenia, arthritis, and connective tissue disease due to inadequate collagen turnover. Cell 1999 99 1 81 92 2-s2.0-2142784516 10.1016/S0092-8674(00)80064-1 (Pubitemid 29468632)
34. Devy L., Huang L., Naa L., Yanamandra N., Pieters H., Frans N., Chang E., Tao Q., Vanhove M., Lejeune A., Van Gool R., Sexton D. J., Kuang G., Rank D., Hogan S., Pazmany C., Ma Y. L., Schoonbroodt S., Nixon A. E., Ladner R. C., Hoet R., Henderikx P., Tenhoor C., Rabbani S. A., Valentino M. L., Wood C. R., Dransfield D. T., Selective inhibition of matrix metalloproteinase-14 blocks tumor growth, invasion, and angiogenesis. Cancer Research 2009 69 4 1517 1526 2-s2.0-60649108677 10.1158/0008-5472.CAN-08-3255
35. Leary R. J., Lin J. C., Cummins J., Boca S., Wood L. D., Parsons D. W., Jones S., Sjöblom T., Park B.-H., Parsons R., Willis J., Dawson D., Willson J. K. V., Nikolskaya T., Nikolsky Y., Kopelovich L., Papadopoulos N., Pennacchio L. A., Wang T.-L., Markowitz S. D., Parmigiani G., Kinzler K. W., Vogelstein B., Velculescu V. E., Integrated analysis of homozygous deletions, focal amplifications, and sequence alterations in breast and colorectal cancers. Proceedings of the National Academy of Sciences of the United States of America 2008 105 42 16224 16229 2-s2.0-55849099654 10.1073/pnas.0808041105
36. Katoh M., Katoh M., MGC9753 gene, located within PPP1R1B-STARD3-ERBB2- GRB7 amplicon on human chromosome 17q12, encodes the seven-transmembrane receptor with extracellular six-cystein domain. International Journal of Oncology 2003 22 6 1369 1374 2-s2.0-0043128956
37. Willis A. L., Tran N. L., Chatigny J. M., Charlton N., Vu H., Brown S. A. N., Black M. A., McDonough W. S., Fortin S. P., Niska J. R., Winkles J. A., Cunliffe H. E., The fibroblast growth factor-inducible 14 receptor is highly expressed in HER2-positive breast tumors and regulates breast cancer cell invasive capacity. Molecular Cancer Research 2008 6 5 725 734 2-s2.0-51049115805 10.1158/1541-7786.MCR-08-0005